Refractory Ulcerative Colitis Improved by Scheduled Combination Therapy of Vedolizumab and Granulocyte and Monocyte Adsorptive Apheresis

Granulocyte and monocyte adsorptive apheresis (GMA) is occasionally introduced as an alternative combination therapy after loss of response to biologics in ulcerative colitis (UC) patients. However, there have been no reports of the concomitant use of vedolizumab (VDZ) and GMA for the initial induct...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Intern Med
Main Authors: Nakamura, Masanao, Yamamura, Takeshi, Maeda, Keiko, Sawada, Tsunaki, Mizutani, Yasuyuki, Ishikawa, Eri, Ohashi, Ayako, Kajikawa, Go, Furukawa, Kazuhiro, Ohno, Eizaburo, Honda, Takashi, Kawashima, Hiroki, Ishigami, Masatoshi, Fujishiro, Mitsuhiro
Formato: Artigo
Idioma:Inglês
Publicado em: The Japanese Society of Internal Medicine 2020
Assuntos:
Case Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7759717/
https://ncbi.nlm.nih.gov/pubmed/32727993
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2169/internalmedicine.5302-20
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados